Update on lymphatic mapping and sentinel node biopsy in the management of patients with melanocytic tumours

被引:36
作者
Cochran, AJ
Roberts, A
Wen, DR
Huang, RR
Itakura, E
Luo, F
Binder, SW
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA USA
[3] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA
关键词
melanoma; sentinel nodes; microscopy; molecular biology; micrometastases; prognosis;
D O I
10.1080/00313020412331282726
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: To communicate best practices for sentinel lymph node evaluation and assessment of prognosis for patients with melanoma. Methods: Description and justification of approaches derive from experience with management of more than 2000 melanoma patients evaluated by lymphatic mapping and sentinel node biopsy (LMSNB). Results: Pathologists, by detecting blue dye or carbon particles or alterations in nodal cell populations should attempt to confirm that a node submitted as sentinel is truly sentinel. Pathologists must adequately sample the node by examining multiple tissue sections and determine the presence or absence of metastatic melanoma using sections stained by H&E and immunocytochemistry. Approximately 20% of patients have melanoma in the sentinel node (SN) and accurate evaluation of SN tumour status is the most precise technique for staging clinically localised cutaneous melanoma. The remaining non-sentinel nodes (NSN) in the basin are tumour-free in 67% of patients with melanoma in the SN. Breslow thickness of the primary, the area of tumour in the SN (relative to total nodal area) and density of dendritic leukocytes in the SN paracortex (factors that are combinable in prognostic algorithms) predict metastases in the NSN and the likelihood of recurrence and melanoma-specific death. Conclusions: Careful pathological analysis is essential to determine the presence or absence of metastatic melanoma in sentinel nodes, findings that indicate whether completion lymphadenectomy is required. Quantitative analysis of the primary melanoma and the amount of tumour in the sentinel node, with evaluation of the dendritic cells in that node, provide invaluable information that predicts non-sentinel node tumour status with increased accuracy and the likelihood of future recurrence and death from melanoma. While these activities require considerable effort from pathologists, their clinical impact justifies the increased workload.
引用
收藏
页码:478 / 484
页数:7
相关论文
共 31 条
[21]   Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma - Therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases [J].
Morton, DL ;
Hoon, DSB ;
Cochran, AJ ;
Turner, RR ;
Essner, R ;
Takeuchi, H ;
Wanek, LA ;
Glass, E ;
Foshag, LJ ;
Hsueh, EC ;
Bilchik, AJ ;
Elashoff, D ;
Elashoff, R .
ANNALS OF SURGERY, 2003, 238 (04) :538-549
[22]   Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy [J].
Ranieri, JM ;
Wagner, JD ;
Azuaje, R ;
Davidson, D ;
Wenck, S ;
Fyffe, J ;
Coleman, JJ .
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (10) :975-981
[23]   PROGNOSTIC FACTORS IN PATIENTS WITH REGIONAL CERVICAL NODAL METASTASES FROM CUTANEOUS MALIGNANT-MELANOMA [J].
SINGLETARY, SE ;
BYERS, RM ;
SHALLENBERGER, R ;
MCBRIDE, CM ;
GUINEE, VF .
AMERICAN JOURNAL OF SURGERY, 1986, 152 (04) :371-375
[24]  
Starz H, 2001, CANCER, V91, P2110, DOI 10.1002/1097-0142(20010601)91:11<2110::AID-CNCR1239>3.3.CO
[25]  
2-H
[26]   Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes [J].
Starz, H ;
Haas, CJ ;
Schulz, GM ;
Balda, BR .
MODERN PATHOLOGY, 2003, 16 (09) :920-929
[27]   Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions - A report on 18 patients [J].
Su, LD ;
Fullen, DR ;
Sondak, VK ;
Johnson, TM ;
Lowe, L .
CANCER, 2003, 97 (02) :499-507
[28]   Lymph node tumor volumes in patients undergoing sentinel lymph node biopsy for cutaneous melanoma [J].
Wagner, JD ;
Davidson, D ;
Coleman, JJ ;
Hutchins, G ;
Schauwecker, D ;
Park, HM ;
Havlik, RJ .
ANNALS OF SURGICAL ONCOLOGY, 1999, 6 (04) :398-404
[29]  
Wen DR, 2003, MODERN PATHOL, V16, p101A
[30]  
WEN DR, 2004, MOD PATHOL S1, V17, pA100